Clinical Trials Related to Mantle Cell Lymphoma

Related studies linked through entity extraction aliases.

Study to Investigate Idelalisib in Combination With Chemotherapeutic Agents, Immunomodulatory Agents and Anti-CD20 Monoclonal Antibody (mAb) in Participants With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

Status: COMPLETED
Phase: PHASE1

Temsirolimus, Bendamustine and Rituximab for Relapsed Follicular Lymphoma or Mantle Cell Lymphoma

Status: COMPLETED
Phase: PHASE1/PHASE2

Study to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL)

Status: COMPLETED
Phase: PHASE3

A Study to Evaluate the Efficacy of Lenalidomide as Maintenance Therapy After Completion of First-line Combination Chemotherapy in Patients With Mantle Cell Lymphoma (MCL).

Status: TERMINATED
Phase: PHASE3

Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma

Status: COMPLETED
Phase: N/A

Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Status: COMPLETED
Phase: PHASE2

Bortezomib, Cladribine, and Rituximab in Treating Patients With Advanced Mantle Cell Lymphoma or Indolent Lymphoma

Status: COMPLETED
Phase: PHASE2

Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma.

Status: COMPLETED
Phase: PHASE1/PHASE2

Study of Bortezomib in Combination With Cyclophosphamide and Rituximab

Status: COMPLETED
Phase: PHASE2

Study of Repeat Intranodal Injections of Ad-ISF35

Status: TERMINATED
Phase: PHASE2

Mantel Cell Lymphoma Efficacy of Rituximab Maintenance

Status: COMPLETED
Phase: PHASE3

Lenalidomide and R-CHOP in B-cell Lymphoma

Status: COMPLETED
Phase: PHASE1/PHASE2

Bendamustine Hydrochloride in Combination With Rituximab in Patients With Relapsed Refractory Mantle Cell Lymphoma

Status: COMPLETED
Phase: PHASE2

Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant

Status: COMPLETED
Phase: PHASE1

Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study

Status: COMPLETED
Phase: PHASE3

A Study to Determine the Efficacy of Lenalidomide Versus Investigator's Choice in Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL)

Status: COMPLETED
Phase: PHASE2

Efficacy and Safety of the Farnesyl-transferase Inhibitor (Tipifarnib) in Mantle Cell Lymphoma

Status: TERMINATED
Phase: PHASE2

A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma

Status: TERMINATED
Phase: PHASE2

Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's Lymphoma

Status: COMPLETED
Phase: PHASE2

A Phase I Clinical Trial of SyB L-0501 in Combination With Rituximab to Patients With Aggressive B-cell Non-Hodgkin's Lymphoma

Status: COMPLETED
Phase: PHASE1